Clinical Trials Logo

FED clinical trials

View clinical trials related to FED.

Filter by:

NCT ID: NCT01618760 Completed - Fed Clinical Trials

Bioequivalence Study of Risperidone Tablet 1 mg Under Fed Condition

Start date: May 2012
Phase: Phase 1
Study type: Interventional

This is a randomized, open Label, balanced, two-treatment, two-period, two-sequence, single dose, crossover pivotal study. The purpose of this study is to assess the bioequivalence between Test Product and the corresponding Reference Product under fed condition in normal, healthy, adult human subjects.

NCT ID: NCT01603186 Completed - Fed Clinical Trials

Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed Condition

Start date: April 2011
Phase: Phase 1
Study type: Interventional

This is a randomized, open Label, two-treatment, two-period, two-sequence, crossover, single dose pivotal study. The purpose of this study is to assess the bioequivalence between Test Product and the corresponding Reference Product under fed condition in normal, healthy, adult, human subjects.

NCT ID: NCT01578265 Completed - Fed Clinical Trials

Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fed Condition

Start date: May 2011
Phase: Phase 1
Study type: Interventional

This is a randomized, open Label, balanced, two-treatment, two-period, two-sequence, single dose, cross over pivotal study. The purpose of this study is to assess the bioequivalence between Test Product and the corresponding Reference Product under fed condition in normal, healthy, adult, human subjects.

NCT ID: NCT01567501 Completed - Fed Clinical Trials

Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed Condition

Start date: February 2012
Phase: Phase 1
Study type: Interventional

This is a single-dose, Randomized, two-period,cross over pivotal study. The purpose of this study is to assess the bioequivalence between Test Product and the corresponding Reference Product under fed condition in normal, healthy, adult, human subjects.

NCT ID: NCT01505998 Completed - Fed Clinical Trials

Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed Conditions

Start date: March 2007
Phase: Phase 1
Study type: Interventional

The purpose of this study single dose bioequivalence of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg capsules with Lotrel® capsules in healthy human subjects and monitor clinical status, adverse events and laboratory investigations and assess relative safety and tolerance under fed conditions.

NCT ID: NCT01503450 Completed - Fed Clinical Trials

Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed Condition

Start date: November 2006
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare the single oral dose bioequivalence of olanzapine 5 mg OD tablets with Zyprexa Zydis 5 mg tablets under fed conditions and to monitor adverse events and ensure safety of subjects.

NCT ID: NCT01503424 Completed - Fed Clinical Trials

Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed Study

Start date: August 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare the bioequivalence and characterize the profile of the olanzapine tablets, 5 mg with zyprexa tablets, 5 mg in healthy, adult, human subjects under fed conditions and to monitor the adverse events and ensure the safety of the subjects.

NCT ID: NCT01372358 Completed - Fed Clinical Trials

Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Non-Fasting Conditions

Start date: January 2005
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare the relative bioavailability of ciprofloxacin 1000 mg ER tablets of Dr.Reddy's with that of CIPRO® XR 1000 mg of Bayer Pharmaceuticals Corporation in healthy, adult, non-smoking subjects under non-fasting conditions.

NCT ID: NCT01372306 Completed - Fed Clinical Trials

Galantamine Bioequivalence Study of Dr. Reddy's Under Fed Condition

Start date: October 2004
Phase: Phase 1
Study type: Interventional

Galantamine Hydrobromide Tablets, Bioequivalence study of Dr. Reddy's under Fed condition.

NCT ID: NCT01314352 Completed - Fed Clinical Trials

Bioavailability Study of Desloratadine 5 mg Tablet of Dr. Reddy's Under Fed Conditions

Start date: December 2005
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare the rate and extent of absorption of Dr. Reddy's Desloratadine 5 mg tablet to that of Clarinex® 5 mg tablet in healthy subjects under fed conditions.